Search - tctmd.com

Displaying 41 - 60 of 62

Sort: Relevancy | Date

News Industry News

Concept Medical Inc. Granted "Breakthrough Device Designation" From FDA for Its MagicTouch Sirolimus Coated Balloon

May 02, 2019

Podcast TCTMD Talking Points

RESET: Seven-Year Follow-up From a Randomized Trial of Sirolimus-Eluting vs Everolimus-Eluting Stents in Patients With Coronary Artery Disease

May 01, 2019

Presentation CIT 2019

A First-in-Man Study of the Firesorb Sirolimus Target Eluting Bioresorbable Scaffold in Patients with Coronary Artery Disease (FUTURE-I) 3-Year Clinical and Imaging Outcomes

Presenter: Bo Xu

March 29, 2019

Presentation CIT 2019

New Drug-Coated Balloon Technologies: Limus and Beyond

Presenter: Bruno Scheller

March 28, 2019

Presentation CIT 2019

A Randomized Trial Comparing a Novel Sirolimus-Eluting Bioresorbable Scaffold with Everolimus-Eluting Metallic Stent in Patients with Coronary Artery Disease: Three-Year Results of NeoVas RCT

Presenter: Yaling Han

March 28, 2019

Presentation CIT 2019

DESSOLVE C: A Randomized Multi-Center Controlled Trial Comparing 2 Biodegradable Polymer-Coated Sirolimus-Eluting Stents in Patients with Coronary Artery Disease

Presenter: Bin Wang, Yaling Han

March 28, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for February 2019

Shelley Wood

March 01, 2019

News Daily News

FDA Approves Orsiro Ultrathin-Strut Stent for CAD

Michael O'Riordan

February 22, 2019

Presentation JIM 2019

12 months results of First-In-Man study with coronary dedicated bifurcation cobalt-chromium sirolimus-eluting stent BiOSS LimC

Presenter: Robert J. Gil

February 15, 2019

Presentation JIM 2019

TALENT: Thin strut sirolimus-eluting stent in all comers population vs Everolimus-eluting stent

Presenter: Giuseppe Tarantini

February 14, 2019

News Daily News

Slight Advantage for DES Over DCB for In-Stent Restenosis: Updated Meta-analysis

Todd Neale

January 15, 2019

Presentation TCT 2018

First Report of the 12-Month Outcomes of SELUTION Trial: A Novel Sirolimus Coated DCB Technology Evaluated in SFA (MedAlliance)

Presenter: George L Adams, Tony Das, Klaus Brechtel

September 21, 2018

Video

Xtreme FIM: Clinical outcome and safety in peripheral vascular disease with Sirolimus Coated Balloon and case report

November 5, 2019

Partner Content

Transforming DCB Strategy: Sirolimus-Coated Balloon With Nanolute Technology - Concept Medical

November 5, 2019

Video

Sirolimus Coated Balloon for treatment of Vasculogenic Erectile Dysfunction. Ready for the prime time

November 5, 2019

Video

Sirolimus Coated Balloon for salvage thrombus arteriovenous graft - Interim results and future RCT design

November 5, 2019

Video

The Magic Touch - PTA Sirolimus Coated Balloon - Insights from pre-clinical evaluation

November 5, 2019

Video

XTOSI study: First In Man study of clinical use and safety of Sirolimus Coated PTA Balloon in the treatment of infrainguinal arterial disease

November 5, 2019

Video

Science behind Nanolute technology of Sirolimus Coated Balloon

November 5, 2019

Partner Content

Future and Scope of Sirolimus-Coated Balloon in Peripheral Vascular Treatment - Concept Medical

November 5, 2019

Advertisement

Concept Medical Inc. Granted "Breakthrough Device Designation" From FDA for Its MagicTouch Sirolimus Coated Balloon

RESET: Seven-Year Follow-up From a Randomized Trial of Sirolimus-Eluting vs Everolimus-Eluting Stents in Patients With Coronary Artery Disease

A First-in-Man Study of the Firesorb Sirolimus Target Eluting Bioresorbable Scaffold in Patients with Coronary Artery Disease (FUTURE-I) 3-Year Clinical and Imaging Outcomes

New Drug-Coated Balloon Technologies: Limus and Beyond

A Randomized Trial Comparing a Novel Sirolimus-Eluting Bioresorbable Scaffold with Everolimus-Eluting Metallic Stent in Patients with Coronary Artery Disease: Three-Year Results of NeoVas RCT

DESSOLVE C: A Randomized Multi-Center Controlled Trial Comparing 2 Biodegradable Polymer-Coated Sirolimus-Eluting Stents in Patients with Coronary Artery Disease

TCTMD’s Top 10 Most Popular Stories for February 2019

FDA Approves Orsiro Ultrathin-Strut Stent for CAD

12 months results of First-In-Man study with coronary dedicated bifurcation cobalt-chromium sirolimus-eluting stent BiOSS LimC

TALENT: Thin strut sirolimus-eluting stent in all comers population vs Everolimus-eluting stent

Slight Advantage for DES Over DCB for In-Stent Restenosis: Updated Meta-analysis

First Report of the 12-Month Outcomes of SELUTION Trial: A Novel Sirolimus Coated DCB Technology Evaluated in SFA (MedAlliance)

Xtreme FIM: Clinical outcome and safety in peripheral vascular disease with Sirolimus Coated Balloon and case report

Transforming DCB Strategy: Sirolimus-Coated Balloon With Nanolute Technology - Concept Medical

Sirolimus Coated Balloon for treatment of Vasculogenic Erectile Dysfunction. Ready for the prime time

Sirolimus Coated Balloon for salvage thrombus arteriovenous graft - Interim results and future RCT design

The Magic Touch - PTA Sirolimus Coated Balloon - Insights from pre-clinical evaluation

XTOSI study: First In Man study of clinical use and safety of Sirolimus Coated PTA Balloon in the treatment of infrainguinal arterial disease

Science behind Nanolute technology of Sirolimus Coated Balloon

Future and Scope of Sirolimus-Coated Balloon in Peripheral Vascular Treatment - Concept Medical

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content